JP7240712B2 - 子宮内膜がんのマーカーとしてのｐｅｒｍ - Google Patents

子宮内膜がんのマーカーとしてのｐｅｒｍ Download PDF

Info

Publication number
JP7240712B2
JP7240712B2 JP2018557905A JP2018557905A JP7240712B2 JP 7240712 B2 JP7240712 B2 JP 7240712B2 JP 2018557905 A JP2018557905 A JP 2018557905A JP 2018557905 A JP2018557905 A JP 2018557905A JP 7240712 B2 JP7240712 B2 JP 7240712B2
Authority
JP
Japan
Prior art keywords
ldha
mmp9
perm
nampt
kpym
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018557905A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019516104A5 (enExample
JP2019516104A (ja
Inventor
ガルシア，エレナ マルティネス
オルテガ，エヴァ コラス
モレノ，アントニオ ギル
プッチジャネー，ジャウメ レベントス
ドモン，ブルーノ
ルシュール，アントワーヌ
Original Assignee
フンダシオ オスピタル ウニベルシタリ バル デブロン－インスティテュート デ レセルカ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フンダシオ オスピタル ウニベルシタリ バル デブロン－インスティテュート デ レセルカ filed Critical フンダシオ オスピタル ウニベルシタリ バル デブロン－インスティテュート デ レセルカ
Publication of JP2019516104A publication Critical patent/JP2019516104A/ja
Publication of JP2019516104A5 publication Critical patent/JP2019516104A5/ja
Priority to JP2023003700A priority Critical patent/JP7492287B2/ja
Application granted granted Critical
Publication of JP7240712B2 publication Critical patent/JP7240712B2/ja
Priority to JP2024077227A priority patent/JP2024116127A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57442—Specifically defined cancers of the uterus and endometrial
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/908—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2018557905A 2016-05-04 2017-03-30 子宮内膜がんのマーカーとしてのｐｅｒｍ Active JP7240712B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023003700A JP7492287B2 (ja) 2016-05-04 2023-01-13 子宮内膜がんのマーカーとしてのｍｍｐ９
JP2024077227A JP2024116127A (ja) 2016-05-04 2024-05-10 子宮内膜がんのマーカーとしてのｍｍｐ９

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16168328.9 2016-05-04
EP16168328 2016-05-04
PCT/EP2017/057635 WO2017190896A1 (en) 2016-05-04 2017-03-30 Mmp9 as marker of endometrial cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023003700A Division JP7492287B2 (ja) 2016-05-04 2023-01-13 子宮内膜がんのマーカーとしてのｍｍｐ９

Publications (3)

Publication Number Publication Date
JP2019516104A JP2019516104A (ja) 2019-06-13
JP2019516104A5 JP2019516104A5 (enExample) 2020-04-23
JP7240712B2 true JP7240712B2 (ja) 2023-03-16

Family

ID=56096908

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018557905A Active JP7240712B2 (ja) 2016-05-04 2017-03-30 子宮内膜がんのマーカーとしてのｐｅｒｍ
JP2023003700A Active JP7492287B2 (ja) 2016-05-04 2023-01-13 子宮内膜がんのマーカーとしてのｍｍｐ９
JP2024077227A Pending JP2024116127A (ja) 2016-05-04 2024-05-10 子宮内膜がんのマーカーとしてのｍｍｐ９

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023003700A Active JP7492287B2 (ja) 2016-05-04 2023-01-13 子宮内膜がんのマーカーとしてのｍｍｐ９
JP2024077227A Pending JP2024116127A (ja) 2016-05-04 2024-05-10 子宮内膜がんのマーカーとしてのｍｍｐ９

Country Status (12)

Country Link
US (2) US20190137499A1 (enExample)
EP (3) EP4610655A3 (enExample)
JP (3) JP7240712B2 (enExample)
AU (3) AU2017260806B9 (enExample)
BR (1) BR112018072498A2 (enExample)
CA (2) CA3286798A1 (enExample)
DK (1) DK3452829T3 (enExample)
ES (1) ES2974307T3 (enExample)
FI (1) FI3452829T3 (enExample)
PL (1) PL3452829T3 (enExample)
PT (1) PT3452829T (enExample)
WO (1) WO2017190896A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7421218B2 (ja) * 2017-07-21 2024-01-24 フンダシオ オスピタル ウニベルシタリ バル デブロン－インスティテュート デ レセルカ 子宮内膜癌のマーカとしてのａｇｒｉｎ
CN118556133A (zh) 2021-07-23 2024-08-27 瓦尔德西布伦大学医院基金会研究所 子宫内膜癌的生物标记物
CN113493838B (zh) * 2021-09-06 2021-11-23 北京泱深生物信息技术有限公司 子宫内膜癌相关的标志分子及其在诊断子宫内膜癌中的应用
KR102640230B1 (ko) * 2021-09-24 2024-02-22 가천대학교 산학협력단 C-peptide를 처리한 자궁내막 기질세포의 이동성 변화 기작을 이용한 자궁내막 관련질환의 진단 방법 및 자궁내막 관련질환 치료제의 스크리닝 방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007202556A (ja) 1997-03-20 2007-08-16 Diagnotech Pty Ltd 子宮内膜ガンの検出
US20080090258A1 (en) 2006-06-28 2008-04-17 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Method and composition for diagnosing endometrial cancer
JP2013500001A (ja) 2009-07-24 2013-01-07 ジアディック・バイオテック・アグルパシオン・デ・インテレス・エコノミコ 子宮内膜がんのマーカー

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US20080226554A1 (en) * 2003-12-23 2008-09-18 Mount Sinai Hospital Methods For Detecting Markers Associated With Endometrial Disease or Phase
WO2008049239A1 (en) * 2006-10-27 2008-05-02 Mount Sinai Hospital Endometrial biomarkers

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007202556A (ja) 1997-03-20 2007-08-16 Diagnotech Pty Ltd 子宮内膜ガンの検出
US20080090258A1 (en) 2006-06-28 2008-04-17 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Method and composition for diagnosing endometrial cancer
JP2013500001A (ja) 2009-07-24 2013-01-07 ジアディック・バイオテック・アグルパシオン・デ・インテレス・エコノミコ 子宮内膜がんのマーカー

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALEX LOPATA; FRANCA AGRESTA ET AL.，DETECTION OF ENDOMETRIAL CANCER BY DETERMINATION OF MATRIX METALLOPROTEINASES IN THE UTERINE CAVITY，GYNECOLOGIC ONCOLOGY，英国，2003年08月，VOL:90, NR:2，PAGE(S):318 - 324，http://dx.doi.org/10.1016/S0090-8258(03)00328-7
ELENA MARTINEZ-GARCIA ET AL.，DEVELOPMENT OF A SEQUENTIAL WORKFLOW BASED ON LC-PRM FOR THE VERIFICATION OF ENDOMETRIAL CANCER PROTEIN BIOMARKERS IN UTERINE ASPIRATE SAMPLES，ONCOTARGET，2016年07月16日，VOL:7, NR:33，PAGE(S):53102 - 53115，http://dx.doi.org/10.18632/oncotarget.10632

Also Published As

Publication number Publication date
EP4180814A2 (en) 2023-05-17
JP2023040246A (ja) 2023-03-22
AU2017260806B9 (en) 2023-07-20
AU2017260806B2 (en) 2023-06-15
JP7492287B2 (ja) 2024-05-29
PL3452829T3 (pl) 2024-05-20
AU2017260806A1 (en) 2018-12-13
EP3452829B1 (en) 2024-01-24
WO2017190896A1 (en) 2017-11-09
US20190137499A1 (en) 2019-05-09
ES2974307T3 (es) 2024-06-26
EP4610655A2 (en) 2025-09-03
AU2023210591B2 (en) 2025-06-26
BR112018072498A2 (pt) 2019-03-12
EP4610655A3 (en) 2025-12-10
EP3452829A1 (en) 2019-03-13
DK3452829T3 (da) 2024-03-25
US20230221323A1 (en) 2023-07-13
CA3022586A1 (en) 2017-11-09
AU2025223935A1 (en) 2025-09-18
CA3286798A1 (en) 2025-10-30
JP2019516104A (ja) 2019-06-13
EP4180814A3 (en) 2023-07-12
AU2023210591A1 (en) 2023-08-24
AU2023210591B9 (en) 2025-07-10
FI3452829T3 (fi) 2024-03-20
JP2024116127A (ja) 2024-08-27
PT3452829T (pt) 2024-03-22

Similar Documents

Publication Publication Date Title
JP7492287B2 (ja) 子宮内膜がんのマーカーとしてのｍｍｐ９
US20240011994A1 (en) Ctnb1 as a marker for endometrial cancer
US20180231559A1 (en) Methods and Compositions for the Diagnosis of Ovarian Cancer
TWI842716B (zh) 泌尿道上皮細胞癌生物標記及其應用
BR122025014970A2 (pt) Método e uso que compreendem kpym para o diagnóstico ou prognóstico de carcinoma endometrial, bem como kit para detectar o nível de expressão de kpym e outros marcadores
BR122023026792A2 (pt) Método e uso da combinação dos marcadores perm e clic1 como marcadores in vitro para diagnosticar ou prognosticar carcinoma endometrial, bem como kit para detectar nível de expressão proteica
BR122024027006A2 (pt) Método para o diagnóstico de câncer endometrial em uma amostra de fluido uterino, kit e método implementado por computador para realizar o dito método diagnóstico e método para decidir ou recomendar um regime médico

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200311

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210126

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210412

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210721

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20210729

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210721

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210729

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211119

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20211119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20211119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220331

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220419

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220818

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20220818

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20220913

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20221031

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20221101

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230113

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230207

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230227

R150 Certificate of patent or registration of utility model

Ref document number: 7240712

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150